Table of contents

Rheumatoid arthritis

• Original research: Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis (30 December, 2022)

  Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas WJ Huizinga, Roy Fleischmann, Jinqi Liu
• Original research:

  MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations

  (29 December, 2022)

  Young Bin Joo, Soo Min Ahn, So-Young Bang, Youngho Park, Su Jin Hong, Youkyung Lee, Soo-Kyung Cho, Chan-Bum Choi, Yoon-Kyoung Sung, Tae-Hwan Kim, Jae-Bum Jun, Dae Hyun Yoo, Sang-Cheol Bae, Hye-Soon Lee
• Original research: Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study (23 December, 2022)

  Liselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, Johan Askling, Saedis Saevarsdottir
• Original research: Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors (22 December, 2022)

  L Terslev, Mikkel Ostergaard, Stylianos Georgiadis, Cecilie Heegaard Brahe, Karen Ellegaard, UM Dohn, Viktoria Fana, Torsten Møller, Lars Juul, Tuan Khai Huynh, Simon Krabbe, L M Ornbjerg, Daniel Glinatsi, Henrik Røgind, Annette Hansen, Jesper Nørregaard, Søren Jacobsen, Dorte V Jensen, Natalia Manilo, Karsten Asmussen, Mikael Boesen, Zoreh Rastiemadabadi, Lone Morsel-Carlsen, Jakob Møllenbach Møller, Niels Steen Krogh, Merete Lund Hetland
• Original research: Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe (22 December, 2022)

  Peter C. Taylor, Bruno Fautrel, Yves Piette, Susana Romero-Yuste, Jasper Broen, Martin Welcker, Oliver Howell, Elke Rottier, Monia Zignani, Katrien Van Beneden, Roberto Caporali, Rieke Alten
• Original research: Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals (19 December, 2022)

  Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, K Mankia, L A Trouw, Paul Emery
• Original research: Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance (13 December, 2022)

  Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, Brett Hauber, Karim Raza, Marie Falahee
• Viewpoint: Mining the pathogenesis of rheumatoid arthritis, the leading role of the environment (12 December, 2022)

  Giovanni Adami
• Original research: Impact of rheumatoid arthritis and methotrexate on pregnancy outcomes: retrospective cohort study of the Italian Society for Rheumatology (12 December, 2022)

  Anna Zanetti, Antonella Zambon, Carlo Alberto Scirè, Alessandra Bortoluzzi
• Editorial: Is there room for better screening for lung cancer in rheumatoid arthritis? (6 December, 2022)

  Chrysoula G Gialouri, George E Fragoulis
• Original research: Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review (6 December, 2022)

  Maike H M Wientjes, Alfons A den Broeder, Paco M J Welsing, Lise M Verhoef, Bart J F van den Bemt
• Original research: Predictors of perceived risk in first-degree relatives of patients with rheumatoid arthritis (5 December, 2022)

  Sarah Bunnewell, Imogen Wells, Dawit Zemedikun, Gwenda Simons, Christian D Mallen, Karim Raza, Marie Falahee
• Original research: Efficacy and drug persistence of baricitinib monotherapy is similar to combination therapy in patients with active RA: a prospective observational study (21 November, 2022)

  Sara Bayat, Koray Tascilar, Daniela Bohr, Gerhard Krönke, David Simon, Johannes Knitza, Fabian Hartmann, Georg Schett, Arnd Kleyer
• Original research: Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial (21 November, 2022)

  Bart P H Pouls, Charlotte L Bekker, Fatma Gundogan, Renske CF Hebing, Hein AW van Onzenoort, Liesbeth I van de Ven, Harald E Vonkeman, Rob Tieben, Johanna E Vriezekolk, Sandra van Dulmen, Bart Van den Bemt
• Short report: A Thermographic Disease Activity Index for remote assessment of rheumatoid arthritis (21 November, 2022)

  Isabel Morales-Ivorra, Javier Narváez, Carmen Gómez-Vaquero, Carmen Moragues, Joan M Nolla, José A Narváez, Manuel Alejandro Marín-López
• Original research: Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors (2 November, 2022)

  Jeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, Ivana Vranic, Burak Sahin, Sara A Paciga, Zhenyu Wang, Craig Hyde, David A Martin
• Original research: Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA (26 October, 2022)

  Kristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, Nicolas Vuilleumier, Magdalena Schwarzmueller, Selina Epp, Sabrina Pagano, Sarah Grabherr, Angelica Brooke Patterson, Madalina Nussberger, Alexandra Trkola, Burkhard Ludewig, Johannes von Kempis, Andrea Rubbert-Roth
• Short report: Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium (21 October, 2022)

  William Murray-Brown, Yanxia Guo, Annabelle Small, Katie Lowe, Helen Weedon, Malcolm D Smith, Susan E Lester, Susanna M Proudman, Navin L Rao, Ling-Yang Hao, Sunil Nagpal, Mihir D Wechalekar
• Letter: Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature (21 October, 2022)

  Thomas Karonitsch, Lusine Yeghiazaryan, Angelika Lackner, Hans Peter Brezinsek, Tanja A Stamm, Franz König, Daniel Aletaha, Josef S Smolen
• Original research: Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking (21 October, 2022)

  Katerina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, Anca Catrina, Johan Askling
• Original research: Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition (30 September, 2022)

  Roswitha Dietzel, Sabine Wiegmann, Diana Borucki, Christian Detzer, Kim Nikola Zeiner, Désirée Schaumburg, Bjoern Buehring, Frank Buttgereit, Gabriele Armbrecht
• Original research: Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis (30 September, 2022)

  Jonathan Kay, Amy E Bock, Muhammad Rehman, Wuyan Zhang, Min Zhang, Noriko Iikuni, Daniel F Alvarez
• Editorial: Overtreatment in rheumatoid arthritis: are there reasons for concern? (30 September, 2022)

  Ricardo J O Ferreira, Laure Gossec, Jose Antonio Pereira da Silva
• Original research: Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis (16 September, 2022)

  George Athanasios Karpouzas, Bianca Papotti, Sarah Ormseth, Marcella Palumbo, Elizabeth Hernandez, Maria Pia Adorni, Francesca Zimetti, Matthew Budoff, Nicoletta Ronda
• Original research: How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? (14 September, 2022)

  Ping-Hsuan Hsieh, Claudia Geue, Olivia Wu, Emma McIntosh, Stefan Siebert
• Original research: Novel insight into the aetiology of rheumatoid arthritis gained by a cross-tissue transcriptome-wide association study (8 September, 2022)

  Jing Ni, Peng Wang, Kang-Jia Yin, Xiao-Ke Yang, Han Cen, Cong Sui, Guo-Cui Wu, Hai-Feng Pan
• Original research: Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts (23 August, 2022)

  Vincent Bouget, Julien Duquesne, Signe Hassler, Paul-Henry Cournède, Bruno Fautrel, Francis Guillemin, Marc Pallardy, Philippe Broët, Xavier Mariette, Samuel Bitoun
• Original research: Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan (22 August, 2022)

  Kooi-Heng Ng, Der-Yuan Chen, Ching-Heng Lin, Wen-Cheng Chao, Hsin-Hua Chen
• Review: 'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps (27 July, 2022)

  Yvonne Tan, Maya H Buch
• Original research: Cost-effectiveness of motivational counselling and text reminders in patients with rheumatoid arthritis: results based on a randomised clinical trial (19 July, 2022)

  Jan Sørensen, Bente Appel Esbensen, Mette Aadahl, Merete Lund Hetland, Tanja Thomsen
• Viewpoint: After 25 years of drug development, do we know JAK? (13 July, 2022)

  Mahta Mortezavi, David A Martin, Hendrik Schulze-Koops
• Review: The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia (12 July, 2022)

  Anna M. P. Boeren, Edwin H. G. Oei, Annette H.M. van der Helm - van Mil
• Original research: Meaning of patient global assessment when joint counts are low in rheumatoid arthritis (23 June, 2022)

  David Felson, Vivi Feathers, Chinmayi Naik, Daniel H Solomon, Michael E Weinblatt, Nancy Shadick
• Original research: Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database (23 June, 2022)

  Raphaele Seror, Alexandre Lafourcade, Yann De Rycke, Sandrine Pinto, Johann Castaneda, Bruno Fautrel, Xavier Mariette, Florence Tubach
• Viewpoint: Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre (17 June, 2022)

  Katja Reuter, Carina Haupt, Anna Molto, Andrew Cope, Ronald F van Vollenhoven, Dirk Elewaut, Rik Lories, Iain B McInnes
• Short report: Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study (15 June, 2022)

  Erik Kemper, Nafise Ghalandari, Hetty Wintjes, Anneke Van Steensel-Boon, Laura Kranenburg, Annemarie Mulders, Hubertina Crijns, Hieronymus Smeele, Radboud J EM Dolhain